Related Experiment Video

Updated: Aug 24, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth

Jianguo Du1, Bo Jiang, Robert J Coffey

  • 1Department of Pediatrics, Center for Cell and Vascular Biology, Columbus Children's Research Institute and Ohio State College of Medicine and Public Health, Columbus, Ohio 43205, USA.

Insights

Co-expressing activated Raf and RhoA transforms intestinal cells, inducing resistance to growth inhibition. Blocking RhoA reduces some Ras-driven changes but doesn't fully reverse the transformed state or TGF-beta sensitivity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Unregulated activation of the Ras/Raf/MAPK pathway drives oncogenic transformation.
  • Raf activation alone is insufficient for tumorigenic transformation in intestinal epithelial cells.
  • Identifying interacting pathways is crucial for understanding intestinal epithelial aberrant growth.

Purpose of the Study:

  • Investigate functional interactions between Raf and RhoA in intestinal epithelial cell transformation.
  • Determine if co-expression of activated Raf and RhoA induces a transformed phenotype.
  • Assess the role of RhoA in Ras-driven intestinal epithelial cell transformation and TGF-beta resistance.

Main Methods:

  • Utilized RIE-1 cells overexpressing activated Raf(22W) and activated RhoA(63L).
  • Assessed morphological transformation, soft agar colony formation, and tumor growth in nude mice.
  • Analyzed expression of cyclin D1, cyclooxygenase-2 (COX-2), and response to transforming growth factor (TGF)-beta.
  • Investigated the effect of dominant-negative RhoA(N19) on RIE-Ras(12V) cells.

Main Results:

  • Co-expression of activated Raf and RhoA led to morphological transformation, soft agar colony formation, tumor growth in vivo, and overexpression of cyclin D1 and COX-2.
  • Double transfectants exhibited resistance to TGF-beta-induced growth inhibition.
  • Single transfectants (Raf or RhoA alone) did not display these transformed characteristics.
  • Blocking RhoA signaling in RIE-Ras cells reduced COX-2 and prostaglandin E2 levels but did not reverse transformed morphology or TGF-beta sensitivity.

Conclusions:

  • Co-expression of activated Raf and RhoA is sufficient to induce transformation and TGF-beta resistance in intestinal epithelial cells.
  • RhoA signaling blockade partially reverses Ras-driven changes but is insufficient to fully reverse the transformed phenotype or restore TGF-beta sensitivity.
  • Additional Rho family members or alternate Ras effector pathways may be involved in reversing the Ras phenotype.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...